10x Genomics Inc. Class A Common Stock (0A88)

Profile

https://www.10xgenomics.com

10x Genomics Inc. is a life science technology company that provides advanced tools for high-resolution analysis of biological systems. The company focuses on single-cell and spatial biology, offering integrated solutions that combine instruments, consumables, and software for researchers worldwide. Its core product portfolio includes the Chromium platform for single-cell and multiomic analysis, enabling detailed transcriptomic profiling, immune profiling, and other genomic applications at the level of individual cells. 10x Genomics also offers the Visium spatial platform for spatial gene expression studies and the Xenium in situ platform for high-plex tissue profiling, supporting work in oncology, immunology, neuroscience, and other complex disease areas. These technologies are used by academic institutions, pharmaceutical and biotechnology companies, and government research organizations to interrogate biological complexity and generate high-dimensional molecular data. Founded in 2012 and headquartered in Pleasanton, California, United States, 10x Genomics operates across the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific, playing a significant role in modern genomics and biomedical research infrastructure.